NASDAQ · NAKA
Nakamoto Inc.
$5.81-$1.07 (-15.52%)
Nakamoto Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.17% below the high.
Loading market information…
NYSE · NEUE · USD
Stock price, earnings
Quote as of Oct 3, 2025, 01:52 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
NeueHealth, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.84% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow NeueHealth, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating within the United States, NeueHealth, Inc. is a healthcare enterprise dedicated to delivering a diverse array of medical solutions to patients, care providers, and insurance entities. The company is structured into two primary divisions. Its NeueCare segment directly offers medical treatment to individuals enrolled in ACA marketplace, Medicare, and Medicaid plans. This is achieved through a network of both company-owned and partner clinics, which frequently operate under a risk-bearing model and include brands such as Centrum Health, AssociatesMD, and Premier Medical Associates. Beyond direct care, NeueCare also encompasses a comprehensive integrated system, featuring on-site pharmacy, laboratory, and radiology facilities, alongside specialized services focused on population health. Furthermore, it provides essential support for managing chronic conditions, coordinating patient transitions between care settings, and streamlining specialist referrals. The NeueSolutions segment, on the other hand, is designed to empower healthcare professionals and medical practices, assisting them in excelling within value-based care agreements. This division also actively works to enhance access to healthcare for Medicare beneficiaries. Established in 2015, the firm is based in Doral, Florida. It adopted the name NeueHealth, Inc. in January 2024, having previously operated as Bright Health Group, Inc.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:07 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2024 | May 8, 2024 | -$2.31+56.42% vs estimate | $245.10M-2.92% vs estimate |
|---|
| Q4 2023 | Mar 6, 2024 | $20.07+582.45% vs estimate | $292.87M-33.77% vs estimate |
|---|
THE ANALYST VIEW
4 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$5.81-$1.07 (-15.52%)
Nakamoto Inc.’s quoted price sits in the lower half of its reported 52-week range, 85.17% below the high.
$1.71-$0.09 (-5.0%)
CareCloud, Inc.’s quoted price sits in the lower half of its reported 52-week range, 55.12% below the high.
$1.07-$0.01 (-0.93%)
Surface Oncology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 25.17% below the high.
$1.29-$0.07 (-5.15%)
Akoya Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 62.28% below the high.
$0.76$0.00 (0.0%)
The Valens Company Inc.’s quoted price sits in the lower half of its reported 52-week range, 74.63% below the high.
$2.38+$0.01 (+0.42%)
Heat Biologics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 4.03% below the high.
$18.20+$16.47 (+952.02%)
Reneo Pharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 78.05% below the high.
$1.48+$0.01 (+0.68%)
Achilles Therapeutics plc’s quoted price sits in the upper half of its reported 52-week range, 1.99% below the high.
